• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans

The compound rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans, with CAS No. 2153916-31-3, is a unique organic molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is characterized by its complex stereochemistry and intriguing structural features, making it a valuable subject for both academic research and potential industrial applications.

The molecular structure of rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans consists of a cyclopropane ring system attached to an ethanamine backbone. The stereochemistry at the (1R,2R) configuration introduces a level of complexity that is often sought after in drug design due to its potential for enantioselective interactions. Recent studies have highlighted the importance of such stereochemically defined compounds in medicinal chemistry, particularly in the development of chiral catalysts and enantiomerically pure drugs.

One of the most notable aspects of this compound is its ability to participate in various chemical reactions under specific conditions. For instance, researchers have explored its reactivity in nucleophilic substitution reactions, where the cyclopropane ring acts as a strained alkene analog. This property has led to its use as a building block in the synthesis of more complex molecules with potential bioactive properties.

In terms of applications, rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans has shown promise in the field of asymmetric catalysis. Its chiral center provides a platform for enantioselective transformations, which are critical in the production of pharmaceuticals and agrochemicals. Recent advancements in catalytic asymmetric synthesis have further underscored the importance of such compounds in achieving high enantiomeric excess (ee) in complex molecule syntheses.

The physical and chemical properties of this compound are equally fascinating. Its melting point and solubility characteristics make it suitable for various analytical techniques, including high-performance liquid chromatography (HPLC) and mass spectrometry. Additionally, its stability under different conditions has been thoroughly investigated, providing valuable insights into its potential for large-scale production and storage.

From a synthetic perspective, the preparation of rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans involves a multi-step process that often includes ring-opening reactions and subsequent amine formation. Researchers have optimized these steps to achieve higher yields and better purity levels, which are essential for its use in downstream applications.

In conclusion, rac-2-[(1R,2R)-2-cyclopropylcyclopropyl]ethan-1-amine, trans, CAS No. 2153916-31-3 stands out as a versatile compound with significant potential in both academic research and industrial applications. Its unique structure and reactivity continue to inspire new avenues of exploration in organic chemistry and pharmacology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)